Keywords: Plexxikon, Roche, PLX4032, Malignant melanma

Plexxikon/Roche’s PLX4032 hailed as cancer's “penicillin moment”

Article | 16 September 2010

Print This

A new cancer drug candidate discovered by the USA’s Plexxikon and licensed to Swiss drug major Roche (SIX: ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in